Structured Summary
Abstract
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
6 entry terms
- Trastuzumab beta
- beta, Trastuzumab
- Herceptin
- Trastuzumab-qyyp
- Trazimera
- Trastuzumab qyyp
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (1998)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Trastuzumab. Medical Subject Headings (MeSH). 2026. Unique ID D000068878. http://id.nlm.nih.gov/mesh/2026/D000068878
- Trastuzumab. In: Wikipedia. https://en.wikipedia.org/wiki/Trastuzumab
- Trastuzumab. In: Wikidata. https://www.wikidata.org/wiki/Q412616